{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T12:23:00Z","timestamp":1777638180873,"version":"3.51.4"},"reference-count":28,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100011421","name":"Sanofi, China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011421","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","clinicaltherapeutics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/j.clinthera.2018.10.018","type":"journal-article","created":{"date-parts":[[2018,11,22]],"date-time":"2018-11-22T06:29:08Z","timestamp":1542868148000},"page":"2125-2137","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Clopidogrel Versus Aspirin for the Treatment of Acute Coronary Syndrome After a 12-Month Dual Antiplatelet Therapy: A Cost-effectiveness Analysis From China Payer's Perspective"],"prefix":"10.1016","volume":"40","author":[{"given":"Lei","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ziyi","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongjun","family":"Yin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianwei","family":"Xuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinthera.2018.10.018_bib1","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.ahj.2015.04.014","article-title":"The China Acute Myocardial Infarction (CAMI) registry: a national long-term registry-research-education integrated platform for exploring acute myocardial infarction in China","volume":"175","author":"Xu","year":"2016","journal-title":"Am Heart J"},{"key":"10.1016\/j.clinthera.2018.10.018_bib2","first-page":"e574","article-title":"2011 ACCF\/AHA\/SCAI guideline for percutaneous coronary intervention: a report of the American college of cardiology foundation\/American heart association task force on practice guidelines and the society for cardiovascular Angiography and interventions","volume":"124","author":"Levine","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.clinthera.2018.10.018_bib3","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1016\/j.jacc.2016.03.513","article-title":"2016 ACC\/AHA guideline focused update on duration of dual antiplatelet therapy in patients with coronary artery disease: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"68","author":"Levine","year":"2016","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.clinthera.2018.10.018_bib4","first-page":"e344","article-title":"2014 AHA\/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes: a report of the American College of Cardiology\/American heart association task force on practice guidelines","volume":"130","author":"Amsterdam","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.clinthera.2018.10.018_bib5","first-page":"382","article-title":"Chinese guideline for percutaneous coronary intervention (2016) [article in Chinese]","volume":"5","author":"Chinese Society of Cardiology","year":"2016","journal-title":"Chin J Cardio"},{"key":"10.1016\/j.clinthera.2018.10.018_bib6","doi-asserted-by":"crossref","first-page":"e002816","DOI":"10.1161\/CIRCINTERVENTIONS.115.002816","article-title":"Clopidogrel versus aspirin as an antiplatelet monotherapy after 12-month dual-antiplatelet therapy in the era of drug-eluting stents","volume":"9","author":"Park","year":"2016","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.clinthera.2018.10.018_bib7","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1007\/s12325-016-0375-9","article-title":"A\u00a0cost-effectiveness analysis of clopidogrel for patients with non-ST-segment elevation acute coronary syndrome in China","volume":"33","author":"Cui","year":"2016","journal-title":"Adv Ther"},{"key":"10.1016\/j.clinthera.2018.10.018_bib8","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1111\/j.1524-4733.2004.75013.x","article-title":"Estimating survival for cost-effectiveness analyses: a case study in atherothrombosis","volume":"7","author":"Caro","year":"2004","journal-title":"Value Health"},{"key":"10.1016\/j.clinthera.2018.10.018_bib9","series-title":"Tabulation on the 2010 Population Census of the People's Republic of China","author":"National Bureau of Statistics of China","year":"2012"},{"key":"10.1016\/j.clinthera.2018.10.018_bib10","series-title":"Report on Cardiovascular Disease in China (2011)","author":"National Center for Cardiovascular Diseases of China","year":"2012"},{"key":"10.1016\/j.clinthera.2018.10.018_bib11","unstructured":"Average bidding price from public websites. Accessed 30 November 2017. https:\/\/db.yaozh.com\/yaopinzhongbiao."},{"key":"10.1016\/j.clinthera.2018.10.018_bib12","unstructured":"Wu J. The direct medical cost among patients with acute coronary syndrome in Tianjin, China, final report, P.45 [internal material]."},{"key":"10.1016\/j.clinthera.2018.10.018_bib13","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s40261-015-0290-x","article-title":"Clopidogrel versus aspirin in patients with recent ischemic stroke and established peripheral artery disease: an economic evaluation in a Chinese setting","volume":"35","author":"Li","year":"2015","journal-title":"Clin Drug Investig"},{"key":"10.1016\/j.clinthera.2018.10.018_bib14","series-title":"2016 China Statistical Yearbook of Health and Family Planning [article in Chinese]","author":"The National Health and Family Planning Commission","year":"2016"},{"key":"10.1016\/j.clinthera.2018.10.018_bib15","first-page":"43","article-title":"The current situation and issues on direct disease burden of intracranial hemorrhage in China [in Chinese]","volume":"24","author":"Wang","year":"2005","journal-title":"Chin Health Econ"},{"key":"10.1016\/j.clinthera.2018.10.018_bib16","first-page":"74","article-title":"Direct economic burden and impacts of hospitalized patients with upper gastrointestinal bleeding [in Chinese]","volume":"12","author":"Lin","year":"2014","journal-title":"Chin Foreign Med Res"},{"key":"10.1016\/j.clinthera.2018.10.018_bib17","series-title":"Ticagrelor for the Treatment of Acute Coronary Syndromes","author":"Zeneca","year":"2012"},{"key":"10.1016\/j.clinthera.2018.10.018_bib18","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1002\/clc.22756","article-title":"Cost-effectiveness analysis of 30-month vs 12-month dual antiplatelet therapy with clopidogrel and aspirin after drug-eluting stents in patients with acute coronary syndrome","volume":"40","author":"Jiang","year":"2017","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.clinthera.2018.10.018_bib19","doi-asserted-by":"crossref","first-page":"261","DOI":"10.2165\/11633820-000000000-00000","article-title":"Economic evaluation of clopidogrel in acute coronary syndrome patients without ST-segment elevation in Greece: a cost-utility analysis","volume":"10","author":"Kourlaba","year":"2012","journal-title":"Appl Heal Econ Heal Pol"},{"key":"10.1016\/j.clinthera.2018.10.018_bib20","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/j.jacc.2004.11.051","article-title":"Long-term cost-effectiveness of clopidogrel given for up to one year in patients with acute coronary syndromes without ST-segment elevation","volume":"45","author":"Weintraub","year":"2005","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.clinthera.2018.10.018_bib21","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1185\/03007990903529267","article-title":"Cost-effectiveness of clopidogrel in STEMI patients in The Netherlands: a model based on the CLARITY trial","volume":"26","author":"Thurston","year":"2010","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.clinthera.2018.10.018_bib22","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.clinthera.2005.01.008","article-title":"The long-term cost-effectiveness of clopidogrel plus aspirin in patients undergoing percutaneous coronary intervention in Sweden","volume":"27","author":"Lindgren","year":"2005","journal-title":"Clin Ther"},{"key":"10.1016\/j.clinthera.2018.10.018_bib23","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1185\/030079908X253762","article-title":"Clopidogrel versus aspirin in patients with atherothrombosis: CAPRIE-based calculation of cost-effectiveness for Germany","volume":"24","author":"Berger","year":"2008","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.clinthera.2018.10.018_bib24","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1185\/030079904X18036","article-title":"Modelling the long term cost effectiveness of clopidogrel for the secondary prevention of occlusive vascular events in the UK","volume":"21","author":"Karnon","year":"2005","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.clinthera.2018.10.018_bib25","first-page":"459","article-title":"Efficacy and safety of low-dose clopidogrel after 12-month dual antiplatelet therapy for patients having drug-eluting stent implantation","volume":"6","author":"Zhuang","year":"2014","journal-title":"J\u00a0Thorac Dis"},{"key":"10.1016\/j.clinthera.2018.10.018_bib26","series-title":"2015 China Guidelines for Pharmacoeconomic Evaluations and Manual","author":"Liu","year":"2015"},{"key":"10.1016\/j.clinthera.2018.10.018_bib27","series-title":"Choosing Interventions that are Cost Effective (WHO-CHOICE), Threshold values for intervention cost-effectiveness by region","author":"WHO","year":"2010"},{"key":"10.1016\/j.clinthera.2018.10.018_bib28","series-title":"Using Cost-effectiveness Thresholds to Determine Value for Money in Low- and Middle-income Country Healthcare Systems: Are Current International Norms Fit for Purpose?","author":"Revill","year":"2014"}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291818305137?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291818305137?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,8]],"date-time":"2019-08-08T08:42:40Z","timestamp":1565253760000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149291818305137"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":28,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["S0149291818305137"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2018.10.018","relation":{},"ISSN":["0149-2918"],"issn-type":[{"value":"0149-2918","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clopidogrel Versus Aspirin for the Treatment of Acute Coronary Syndrome After a 12-Month Dual Antiplatelet Therapy: A Cost-effectiveness Analysis From China Payer's Perspective","name":"articletitle","label":"Article Title"},{"value":"Clinical Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinthera.2018.10.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}